36 Meteor Drive
Toronto, ON M9W 1A4
Canada
https://www.sqidiagnostics.com
Sector(es): Healthcare
Industria: Diagnostics & Research
Empleados a tiempo completo:
Nombre | Título | Pagar | Ejecutado | Año de nacimiento |
---|---|---|---|---|
Mr. Andrew Morris | Advisor to the Board & CEO | 396.38k | N/D | 1966 |
Mr. Morlan Reddock C.F.A., CPA, CGA, M.B.A. | CFO & VP of Administration | 145.99k | N/D | N/D |
Dr. Eric Brouwer Ph.D. | Chief Scientific Officer & Advisor to the Board | 255.48k | N/D | 1969 |
Dr. Peter Lea Ph.D. | Founder | N/D | N/D | 1945 |
Mr. Tim McGough | Chief Commercial Officer | N/D | N/D | N/D |
SQI Diagnostics Inc., a precision medicine company, discovers, develops, and commercializes rapid diagnostic testing services for healthcare providers, patients, and consumers worldwide. The company also offers TOR-dx, a lung test, which enables the surgeon to assess the health of the donor's lung; and a COVID-19 at-home antibody test kit; the RALI-Dx, a COVID-19 severity triage lab test; and RALI-fast, a COVID-19 severity triage POC test. In addition, it offers microarray tests for protein and antibody testing workflow. The company was founded in 1999 and is headquartered in Toronto, Canada.
La calificación ISS Governance QuickScore de SQI Diagnostics Inc. a partir del N/D es N/D. Las puntuaciones principales son Auditoría: N/D; Junta: N/D; Derechos del accionista: N/D; Compensación: N/D.